Home / News
-
-
Recently, BD (Becton, Dickinson and Company) announced the appointment of Puneet Sarin as the global president of BD Bioscience, which took effect on the same day.2019-06-26View More
-
-
Recently, the 2019 Siemens Pharmaceutical Industry Summit was successfully held in Chengdu. During the conference, the world's leading biopharmaceutical industry supplier Sartorius Stedim Biotech and Siemens announced ...2019-06-26View More
-
-
Personalis announced recently that it has priced its initial public offering of around 7.9 million shares of common stock at $17 per share.2019-06-26View More
-
-
Amoy Diagnostics, Premia Holdings, and Loxo Oncology recently announced a partnership aimed at genetic screening of patients for a targeted cancer therapy.2019-06-26View More
-
-
Almac Diagnostic Services recently announced that it has received CE marking for a next-generation sequencing-based diagnostic assay that will be used to ...2019-06-26View More
-
-
Thermo Fisher Scientific recently announced a number of new partnerships in conjunction with the annual American Society for Mass Spectrometry Conference in Atlanta.2019-06-26View More
-
-
Horizon Therapeutics has partnered with Invitae for its urea cycle disorder genetic (UCD) testing program, through which individuals who may have the rare genetic condition and their family members will receive testing at no charge.2019-06-26View More
-
-
Becton Dickinson reported today that its fiscal second quarter revenues decreased approximately 1 percent year over year.2019-05-31View More
-
-
Hologic announced today that the US Food and Drug Administration has cleared two of its infectious disease assays for common causes of a condition called vaginitis.2019-05-31View More
-
-
Roche today announced the CE-IVD marking of its Cobas MTB-RIF/INH test that detects mutations associated with resistance to the antibiotics rifampicin and isoniazid within tuberculosis DNA.2019-05-31View More
-
-
Investment Plan for Europe: Mobidiag secures EUR 25 million from EIB Funds will be used to accelerate the development and commercialisation of in vitro diagnostic solutions for infectious diseases.2019-05-31View More
-
-
Hologic reported after the close of the market on Wednesday that its fiscal second quarter revenues rose 4 percent year over year, driven by strong sales in its molecular diagnostics business.2019-05-31View More
-
-
Bio-Techne said today that its 2019 fiscal third quarter revenues rose 13 percent year over year, driven by double-digit organic growth in North America, Europe, and China.2019-05-31View More
-
-
Bio-Rad Laboratories reported after the close of the market Wednesday that its first quarter revenues rose a fraction of a percent year over year, besting Wall Street estimates.2019-05-31View More
-
-
Agilent Technologies reported after the close of the market on Tuesday that its fiscal second quarter revenues rose 3 percent year over year.2019-05-31View More
-
-
The US Food and Drug Administration has approved Qiagen's Therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for identifying which advanced breast cancer patients have PIK3CA mutations and are likely to respond to Novartis' alpelisib (Piqray).2019-05-29View More
-
-
Roche said recently that it has received US Food and Drug Administration 510(k) clearance for its Cobas TV/MG test for the detection of Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) DNA in symptomatic and asymptomatic patients.2019-05-29View More
-
-
PreludeDx said recently that the State of New York Clinical Laboratory Evaluation Program (CLEP) has approved its DCISionRT test2019-05-27View More
-
-
On May 20, 2019, Thermo Fisher Scientific announced that it is investing more than $50 million into its global bioproduction capabilities.2019-05-27View More
-
-
Velano Vascular has secured $10 million as the initial tranche of a growth financing to fuel commercialization and the launch of new vascular access solutions.2019-05-27View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.